TG Therapeutics Inc


Market Cap$2.59B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
TG Therapeutics IncTG Therapeutics Inc62.30%26%170.6

Target Price by Analysts

188.6% upsideTG Therapeutics Target Price DetailsTarget Price

Current Fair Value

4.7% downside

Overvalued by 4.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.59 Billion
Enterprise Value$2.48 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.28
Outstanding Shares154,542,945
Avg 30 Day Volume2,207,687


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio62.28
Price to Sales16.98
Price to Book Ratio16.98
Enterprise Value to Revenue8.58
Enterprise Value to EBIT51.32
Enterprise Value to Net Income59
Total Debt to Enterprise0.04
Debt to Equity0.63

Revenue Sources

No data

Insider Trades

ESG Score

No data

About TG Therapeutics Inc

CEO: Michael Weiss